⌘K

Login Start Free

Home/Filings/4/0001264124-03-000015

4//SEC Filing

AMYLIN PHARMACEUTICALS INC 4

Accession 0001264124-03-000015

CIK 0000881464operating

View on SEC.gov Company Profile

Filed

Oct 16, 8:00 PM ET

Accepted

Oct 17, 2:08 PM ET

Size

13.2 KB

Accession

0001264124-03-000015

Insider Transaction Report

Form 4

Period: 2003-10-17

AMYLIN PHARMACEUTICALS INCAMLN

Sr VP Regulatory Affairs & QA

Transactions

Sale
Common Stock
2003-10-17$27.61/sh−6,900$190,509→ 61,612 total
Exercise/Conversion
Incentive Stock Option (right to buy)
2003-10-16−2,470→ 24,754 total
Exercise: $2.50From: 2003-10-17Exp: 2009-08-11→ Common Stock (2,470 underlying)
Tax Payment
Common Stock
2003-10-16$28.40/sh−4,539$128,908→ 68,512 total
Exercise/Conversion
Common Stock
2003-10-16$2.50/sh+2,470$6,175→ 50,553 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2003-10-16−22,498→ 13,125 total
Exercise: $5.73From: 2003-10-17Exp: 2011-10-04→ Common Stock (22,498 underlying)
Exercise/Conversion
Common Stock
2003-10-16$5.73/sh+22,498$128,914→ 73,051 total

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

AMYLIN PHARMACEUTICALS INC

CIK 0000881464

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000881464

Filing Metadata

Form type: 4
Filed: Oct 16, 8:00 PM ET
Accepted: Oct 17, 2:08 PM ET
Size: 13.2 KB

View on SEC.gov